Ypsomed Holding AG (LTS:0QLQ) Total Premiums Earned

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QLQ Ypsomed Holding AG LTS:0QLQ
86 GF Score
Price CHF397.90
GF Value CHF394.90
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.

LTS:0QLQ
86GF Score
Ypsomed Holding AG LTS:0QLQ
Total Premiums Earned is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ypsomed Holding AG (LTS:0QLQ) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be overvalued. The current stock price of CHF397.90 is trading 0.8% above its estimated GF Value™ of CHF394.90. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for LTS:0QLQ:

  • Total Premiums Earned:
  • GF Value™: CHF394.90 vs. price of CHF397.90 (0.8% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the LTS:0QLQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
86GF Score

Get the complete analysis for LTS:0QLQ

Total Premiums Earned is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF397.90
Price
CHF394.90
GF Value